Oncology Nursing News Hosts Tweet Chat on Oncology Nursing Society's Annual Conference
Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's Annual Conference, held May 17-20 in Washington, DC.
Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's (ONS) Annual Conference, held May 17-20 in Washington, DC.
“We are excited to launch the inaugural tweet chat on the oncology nursing society’s annual conference. This tweet chat will inform the audience on the highlights and news that came out of the conference,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of Oncology Nursing News®.
Oncology Nursing News® welcomes all professionals within the oncology nursing specialty group to join the discussion using the hashtag #OncNurseConnect. Highlights to be discussed:
- Clinical practice
- Leadership management education
- Advanced practice
- Research
- Professional development
Read more ONS Congress conference coverage
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
Maintained QOL, Neurological Function Support T-DXd Safety and Efficacy in HER2+ mBC
December 20th 2024In line with its safety and efficacy profile, T-DXd preserved quality of life and neurological function in patients with HER2-positive metastatic breast cancer, irrespective of brain metastases.
